🇺🇸 FDA

Drug profile · INN

dupilumab

DUPIXENT

approved D11AH05
US status
approved
Patents linked
0
News articles
1

Quick answer

dupilumab (DUPIXENT) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron UK Limited. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN dupilumab
Brand DUPIXENT
Route INJECTION
Formulation INJECTABLE
ATC code D11AH05
Originator Regeneron UK Limited

Frequently asked questions

What is dupilumab?

dupilumab (DUPIXENT) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron UK Limited. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for dupilumab?

DUPIXENT is a marketed brand name for dupilumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of dupilumab?

dupilumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.